CCeReg is a comprehensive 21 CFR Part 11 compliant electronic regulatory document management solution that helps research organizations ensure regulatory compliance, eliminate the cost and inefficiency of paper binders and maintain audit readiness.
Why CCeReg ?
Stay Compliant
- Be organized, current and audit-ready
- Ensure timely eSignatures from any location
- Automatically monitor credentialing and licensure
Avoid Study Deviations
- Automate deadline notifications
- Stay on schedule with remote PI eSignatures
- Automate version control
Negotiate Better
- Optimize study startup metrics and reports
- Share regulatory documents with reviewers easily
- Provide remote monitoring for sponsors
Accelerate Startup Time
- Automate status, deadline and alert notifications
- Minimize interruptions with workflow imbedded eSignatures
- Track milestones and expiration dates
Decrease Staff Workload
- Stay organized with transparent workflows
- Maximize team effectiveness with standardized processes
- Avoid mistakes with current version tracking
Eliminate Paper Binder Costs
- Eliminate storage and retrieval costs
- Turn binder supply costs into a distant memory
- Increase efficiency while reducing labor costs
Calculate Your Savings
Get a Copy of Your Results
What Our Customers Say
“Since implementing CC CTMS, my recruitment staff has been able to make more calls each day; more calls mean more patients, and more patients mean more funding for our sites.”
“Integrating CC CTMS with Facebook means our team is able to reach out to prospective patients in near real time, allowing for conversations with engaged prospects, rather than cold leads.”
Clinical Research Resources
Blog Post
The COVID-19 pandemic has caused an enormous disruption in healthcare priorities and staffing, and as restrictions on people’s movement have increased, clinical research sites face unprecedented challenges to adjust studies and patient engagement accordingly. The FDA has provided guidance to support ongoing continuity and response efforts, wherein the safety of trial participants is paramount. It […]
